Cart
sales@molnova.com
BGB 15025
CAS No. 2766481-17-6
BGB 15025( ——— )
Catalog No. M39443 CAS No. 2766481-17-6
HPK1-IN-32 is a potent and selective HPK1 inhibitor with an IC50 of 65 nM. HPK1-IN-32 can be used for the research of HPK1 related disorders or diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBGB 15025
-
NoteResearch use only, not for human use.
-
Brief DescriptionHPK1-IN-32 is a potent and selective HPK1 inhibitor with an IC50 of 65 nM. HPK1-IN-32 can be used for the research of HPK1 related disorders or diseases.
-
DescriptionHPK1-IN-32 is a potent and selective HPK1 inhibitor with an IC50 of 65 nM. HPK1-IN-32 can be used for the research of HPK1 related disorders or diseases.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorHPK1
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number2766481-17-6
-
Formula Weight536.64
-
Molecular FormulaC28H37FN8O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL (93.17 mM; ultraphonic; )
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sanjia XU, et al. 3-(1h-pyrazol-4-yl)oxypyrazin-2-amine compounds as hpk1 inhibitor and use thereof. Patent. WO2022068848.
molnova catalog
related products
-
3-Amino-2-oxazolidin...
3-Amino-2-oxazolidinone (AOZ) is the metabolite of Furazolidone. It is always be detected as a indicator of furazolidone residues in vivo.
-
Mahanimbine
Mahanimbine is found in the roots, leaves and stems of Murraya koenigii and is an orally active alkaloid extracted from Murraya koenigii.
-
c(Bua-Cpa-Thi-Val-As...
c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm a highly efficient, selective and short-acting peptide V2 receptor agonist (V2R), with EC50s of hV2R and rV2R being 0.25 and 0.05 nM, respectively.
